Pivotal bioVenture Partners Investment Advisor LLC: BRVE position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Pivotal bioVenture Partners Investment Advisor LLC on BRVE, newest first. How the timeline and the estimate are built.
Pivotal bioVenture Partners Investment Advisor LLC held 317,351 BRVE shares at 2026-09-30 per its 13F-HR filed 2026-11-13.
the latest 13F is the newest step
- period ended2026-09-3013F 317,351 sharesChange vs previous 13F not available
2.55% of the 13F portfolio, value $6,410,490.
13F-HR 0001012975-26-001045 filed by Pivotal bioVenture Partners Investment Advisor LLC
Accepted , ingested